Familial pseudohyperkalaemia (FP) is a symptomless, dominantly inherited red cell trait, which shows a 'passive leak' of K þ cations into the plasma upon storage of blood at room temperature (or below). There are no haematological abnormalities. The loss of K þ is due to a change in the temperature dependence of the leak. The Scottish case initially described, FP Edinburgh, maps to 16q23-qter. Here we studied a large kindred of Flemish descent with FP, termed FP Lille, which was phenotypically identical to the Edinburgh FP. In FP Lille, however, the responsible locus mapped to 2q35-36, with a Lod score of 8.46 for marker D2S1338. We infer that FP Edinburgh and FP Lille, although they are phenocopies of one another, stem from two distinct loci, FP1 (16q23-qter) and FP2 (2q35-36), respectively. This duality hints at the possibility that the protein mediating the leak might be a heterodimer. No mutation was found in three plausibly candidate genes: the KCNE4 gene, the TUBA1 gene and a predicted gene located in genomic contig NT_005403.
Introduction
Familial pseudohyperkalaemia (FP) is a dominantly inherited genetic trait, in which a temperature-dependent, in vitro, loss of K þ cations from red cells is associated with normal haematology. 1 The basic physiopathological abnormality lies in the temperature dependence of the 'passive leak' to K þ across the red cell membrane. FP 'Edinburgh' was the original case discovered. 1 These cases can be diagnosed by measuring K þ movements across the red cell membrane as a function of temperature. Typically, heparinised red cells will lose abnormal amounts of K þ at both 20 and 01C due to an abnormality in the temperature dependence of the so-called 'passive leak' to K þ . This abnormality in temperature dependence of the leak can be confirmed using isotopic tracer techniques. 2, 3 The responsible gene maps to 16q23-qter. 2 . We present here a large 
Methods
The family has previously been described. 4 After informed consent from each subject, we studied 34 members, of which 23 were carrying the trait. The in vitro increase of plasma [K þ ], the fluxes of K þ across the membrane and the dependence of the leak -temperature curve were studied as previously described (Grootenboer et al 5 , and references therein) ( Figure 1 ). Members with kalaemia Z7 mmol/l after 6 h of incubation at 91C were considered as carrying the FP trait. Those with kalaemia r6 mmol/l under the same conditions were considered as not carrying the trait. Four members were not included in the gene scan because the increase of kalaemia was ambiguous (III.8 and III.18), or technical problems had occurred (II.10 (no DNA spared) and III.12 (haemolysis)). The 16q23-qter region had been explored using microsatellites D16S511, D16S402, D16S3037, D16S520, D16S498, and D16S3074 in the centromer -telomer direction, according to procedures described previously. 5 As linkage with chromosome 16 was excluded, a gene scan was undertaken. The ABI PRISM Linkage Mapping Set v2 (Perkin-Elmer, Foster City, CA, USA) was used under the conditions suggested by the manufacturer. Additional markers were used in order to refine the region of interest. An aliquot of each PCR reaction was run on an ABI PRISM 3100 DNA sequencer and results were processed by GENESCAN software. Allele assignation was carried out using the Genotypert software. Statistical analysis was performed on the basis of an autosomal disease with complete penetrance. Pairwise linkage analysis was performed using the MLINK program version 5.1 from the LINKAGE computer package. 6 Values for maximum LOD score were calculated with the ILINK program from the same computer package. (The approximate 95% confidence limits for the maximum recombination fraction (Theta max ) at the maximum LOD score (Z max ) were calculated by the 1-LOD-down method.) 6 Alleles were down coded without loss of informativity to reduce the computing time. The multipoint parametric analysis was performed by SimWalk2 v.2.82 using Markov chain Monte Carlo (MCMC) and simulated annealing algorithms. 7 We sequenced three tentatively candidate genes: the KCNE4 gene, encoding a potassium voltage-gated channel, Isk-related, the TUBA1 gene, encoding tubulin a1, and a predicted gene encoding an ABC transporter and located in genomic contig NT_005403 (data not shown).
Results
The carriers were haematologically normal (not shown). Pseudohyperkalaemia was assessed in 23 carriers vs 11 noncarriers. At t ¼ 0 h, kalaemias (mmol/l;72s) were: 4.370.5 vs 4.170.36. The difference between the means was nonsignificant at Po0.001. After 6 h of incubation at 221C, kalaemias were 11.373.46 vs 5.270.82 (difference significant at Po0.001). After 6 h of incubation at 91C, they were 6.271.88 and 4.270.86 (difference significant at Po0.001) (Figure 1 Figure 1 The in vitro increase of kalaemia at 22 and 91C. At 221C blood incubation (6 h), kalaemia raised moderately in patients with FP2 (m72SD: 6.372 mmol/l) as compared to normal subjects (4.270.6). seen in the normal, was obtained, which was essentially identical to that seen in FP Edinburgh. 8, 9 The microsatellite study in 16q23-qter excluded the presence of a mutant gene in the 16q23-qter region (Figure 2) .
On the other hand, a gene scan allowed to map the searched locus to 2q35 -36 (Figure 3) . Pairwise linkage analysis showed a maximum Lod score of 5.36 with marker D2S126 (Table 1) . Negative results were obtained for all the remaining loci investigated in the genome-wide search. Additional markers (D2S301, D2S2395, D2S1338, D2S2250, D2S163, D2S2197, D2S1363) were employed to narrow down the region of interest; pairwise linkage data strengthened the preliminary data. The highest LOD score (8.46) was obtained with marker D2S1338. Multipoint linkage analysis showed a location score of 11.1 very close to marker D2S2250. Recombinants and multipoint linkage analysis define an FP2 candidate region of approximately 4 cM.
The 2q35 -36 region contains 68 sequences (47 pertaining to cloned genes and 21 to unknown gene).
Sequencing of the KCNE4 gene, the TUBA1 gene and the predicted ABC transporter gene failed to reveal any change.
Discussion
The haematological abnormality of familial pseudohyperkalaemia is negligible, but the patients present with Figure 2 The family tree and the haplotypes (16q23-qter region). White squares and circles: normal members. Black halfsquares and half-circles: FP carriers. Arrow: the proband. Several instances allowed to exclude the 16q23-qter region, in particular, the absence of relationship, whichever recombination event might have occurred, between the haplotypes of carriers II.6, II.9 and II.14 and parent carrier I.1. Figure 3 The family tree and the haplotypes (2q35 -36 region). White squares and circles: normal members. Black halfsquares and half-circles: FP carriers. Arrow: the proband. The 2q35 -36 region. Grey circles or squares: nonstudied member (see text). Alleles 11 and 8 of markers D2S1338 and D2S2250, respectively, were constantly associated with FP2.
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pseudohyperkalaemia observed in the samples stored for few hours at room temperature. This condition is linked to stomatocytosis as demonstrated in several trees, where stomatocytosis, perinatal oedema and familial pseudohyperkalaemia coexist.
5
To date, three types of pseudohyperkalaemia devoid of haematological signs have been found, based mostly on the leak -temperature dependence curve: (i) FP Edinburgh 1 and Lille (this work), in which the curve has a shallow slope, (ii) FP Chiswick and Falkirk, 9 in which the curve is shouldered and (iii) FP Cardiff, 10 in which the temperature dependence of the leak shows a 'U-shaped' profile with a minimum at 231C. Pseudohyperkalaemia has also been found in association with haematological manifestations. In a class of families, 5 pseudohyperkalaemia was associated with dehydrated hereditary stomatocytosis (DHS). The leak -temperature dependence curve had the same shallow slope as in FP Edinburgh or Lille; only was it slightly translated upward along the y-axis. One DHS þ pseudohyperkalaemia case mapped to 16q23-qter. 4, 11 To which extent this combination maps to 16q23-qter is yet to be assessed. It is puzzling that an extremely rare trait such as pseudohyperkalaemia can still split into three genetic entities, and that the first of these entities can further split in two subentities. FP Edinburgh stems from FP1 locus (16q23-qter) and FP Lille from FP2 locus (2q35 -36). These clinical conditions demonstrate the genetic heterogeneity of Familial Psedohyperkalaemia. In consideration of the clinical and laboratory data, we could consider as candidate genes ion channel or protein related to this transport. Tentative sequencing of three plausibly candidate genes in the region of interest yielded negative results. 
